Racial and ethnic disparities in idiopathic pulmonary fibrosis: A UNOS/OPTN database analysis

American Journal of Transplantation

Volumn 6, Issue 10, 2006, Pages 2436-2442

  Lederer, D J ^a   Arcasoy, S M ^a   Barr, R G ^a,b   Wilt, J S ^a   Bagiella, E ^b   D'Ovidio, F ^a   Sonett, J R ^a   Kawut, S M ^a,b  

^a Columbia University ^*  (United States)

^b NONE   (United States)

Author keywords

Cohort; Diffuse parenchymal lung disease; Forced vital capacity; Interstitial lung disease; Lung transplantation

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DATA BASE; ETHNIC DIFFERENCE; EUROPEAN AMERICAN; FEMALE; FORCED EXPIRATORY VOLUME; HISPANIC; HUMAN; LUNG FIBROSIS; LUNG FUNCTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; SOCIOECONOMICS; SURVIVAL RATE;

CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY FIBROSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; UNITED STATES;

EID: 33748498731     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01480.x     Document Type: Article

References (41)

1. King TE, Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: Scoring system and survival model. Am J Respir Crit Care Med 2001; 164: 1171-1181.
2. Schwartz DA, Helmers RA, Galvin JR et al. Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1994; 149: 450-454.
3. Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001; 134: 136-151.
4. Coultas DB, Zumwalt RE, Black WC, Sobonya RE. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 1994; 150: 967-972.
5. Trulock EP, Edwards LB, Taylor DO, Boucek MM, Keck BM, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: Twenty-second official adult lung and heart-lung transplant report-2005. J Heart Lung Transplant 2005; 24: 956-967.
6. The American Society for Transplant Physicians (ASTP)/American Thoracic Society (ATS)/European Respiratory Society (ERS)/International Society for Heart and Lung Transplantation (ISHLT). International guidelines for the selection of lung transplant candidates. Am J Respir Crit Care Med 1998; 158: 335-339.
7. Collard HR, King TE, Bartelson BB, Vourlekis JS, Schwarz MI, Brown KK. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003; 168: 538-542.
8. Flaherty KR, Mumford JA, Murray S et al. Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003; 168: 543-548.
9. Latsi PI, du Bois RM, Nicholson AG et al. Fibrotic idiopathic interstitial pneumonia: The prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 2003; 168: 531-537.
10. Lama VN, Flaherty KR, Toews GB et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003; 168: 1084-1090.
11. Hallstrand TS, Boitano LJ, Johnson WC, Spada CA, Hayes JG, Raghu G. The timed walk test as ameasure of severity and survival in idiopathic pulmonary fibrosis. Eur Respir J 2005; 25: 96-103.
12. Kawut SM, O'Shea MK, Bartels MN, Wilt JS, Sonett JR, Arcasoy SM. Exercise testing determines survival in patients with diffuse parenchymal lung disease evaluated for lung transplantation. Respir Med 2005; 99: 1431-1439.
13. King TE, Schwarz MI, Brown K et al. Idiopathic pulmonary fibrosis: Relationship between histopathologic features and mortality. Am J Respir Crit Care Med 2001; 164: 1025-1032.
14. Mapel DW, Hunt WC, Utton R, Baumgartner KB, Samet JM, Coultas DB. Idiopathic pulmonary fibrosis: Survival in population based and hospital based cohorts. Thorax 1998; 53: 469-476.
15. Mannino DM, Etzel RA, Parrish RG. Pulmonary fibrosis deaths in the United States, 1979-1991. An analysis of multiple-cause mortality data. Am J Respir Crit Care Med 1996; 153: 1548-1552.
16. Lederer DJ, Caplan-Shaw CE, O'Shea MK et al. Racial and ethnic disparities in survival in lung transplant candidates with idiopathic pulmonary fibrosis. Am J Transplant 2006; 6: 398-403.
17. Lederer DJ, Arcasoy SM, Barr RG et al. Disparities in survival in minority patients with idiopathic pulmonary fibrosis [abstract]. Proc Am Thor Soc 2006; 3: A523.
18. Christie JD, Kotloff RM, Ahya VN et al. The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med 2005; 171: 1312-1316.
19. Office of Management and Budget. Available from: http://www.whitehouse. gov/omb/fedreg/directive 15.html (Accessed June 29, 2006).
20. Wisnivesky JP, McGinn T, Henschke C, Hebert P, Iannuzzi MC, Halm EA. Ethnic disparities in the treatment of stage I non-small cell lung cancer. Am J Respir Crit Care Med 2005; 171: 1158-1163.
21. U.S. Department of Commerce, Bureau of the Census. Census of Population and Housing, 2000 [United States]: Summary file 3, National [computer file]. Washington, D.C.: I.S. Department of Commerce, Bureau of the Census [producer], 2002. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2002.
22. Dickinson DM, Bryant PC, Williams MC et al. Transplant data: Sources, collection, and caveats. Am J Transplant 2004; 4(Suppl 9): 13-26.
23. Crowley J, Hu M. Covariance analysis of heart transplant survival data. J Am Stat Assoc 1977; 72: 27-36.
24. Hosenpud JD, Bennett LE, Keck BM, Edwards EB, Novick RJ. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998; 351: 24-27.
25. Charman SC, Sharples LD, McNeil KD, Wallwork J. Assessment of survival benefit after lung transplantation by patient diagnosis. J Heart Lung Transplant 2002; 21: 226-232.
26. Cox DR, Oakes D. Analysis of Survival Data. New York: Chapman and Hall, 1984.
27. Grant EN, Lyttle CS, Weiss KB. The relation of socioeconomic factors and racial/ethnic differences in US asthma mortality. Am J Public Health 2000; 90: 1923-1925.
28. Margolis ML, Christie JD, Silvestri GA, Kaiser L, Santiago S, Hansen-Flaschen J. Racial differences pertaining to a belief about lung cancer surgery: Results of a multicenter survey. Ann Intern Med 2003; 139: 558-563.
29. Kawut SM, Horn EM, Berekashvili KK et al. New predictors of outcome in idiopathic pulmonary arterial hypertension. Am J Cardiol 2005; 95: 199-203.
30. Bach PB, Pham HH, Schrag D, Tate RC, Hargraves JL. Primary care physicians who treat blacks and whites. N Engl J Med 2004; 351: 575-584.
31. Delaney NL, Esquenazi V, Lucas DP, Zachary AA, Leffell MS. TNF-alpha, TGF-beta, IL-10, IL-6, and INF-gamma alleles among African Americans and Cuban Americans. Report of the ASHI Minority Workshops: Part IV. Hum Immunol 2004; 65: 1413-1419.
32. Hoffmann SC, Stanley EM, Cox ED et al. Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2002; 2: 560-567.
33. Suthanthiran M, Li B, Song JO et al. Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and(or target organ damage. Proc Natl Acad Sci USA 2000; 97: 3479-3484.
34. Department of Health and Human Services. Healthy People 2010: Understanding and Improving Health, 2nd Ed. Washington, D.C.: Government Printing Office, 2000.
35. Johnston ID, Prescott RJ, Chalmers JC, Rudd RM. British Thoracic Society study of cryptogenic fibrosing alveolitis: Current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society. Thorax 1997; 52: 38-44.
36. Kocheril SV, Appleton BE, Somers EC et al. Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia. Arthritis Rheum 2005; 53: 549-557.
37. Rosas V, Conte JV, Yang SC et al. Lung transplantation and systemic sclerosis. Ann Transplant 2000; 5: 38-43.
38. American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Resp Crit Care Med 2002; 165: 277-304.
39. Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006; 129: 746-752.
40. Nadrous HF, Pellikka PA, Krowka MJ et al. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest 2005; 128: 2393-2399.
41. Whelan TP, Dunitz JM, Kelly RF et al. Effect of preoperative pulmonary artery pressure on early survival after lung transplantation for idiopathic pulmonary fibrosis. J Heart Lung Transplant 2005; 24: 1269-1274.